The Scientist

» twitter and immunology

Most Recent

image: CRISPR Trial for Cancer Patients Proposed

CRISPR Trial for Cancer Patients Proposed

By | January 19, 2018

US researchers could become the first outside China to use the gene-editing technique in the clinic. 

0 Comments

The discovery reveals the role of a growth factor and endothelial cells in thymus repair, and could have implications for chemotherapy and radiation patients’ recovery following treatment.

0 Comments

image: Scientists Continue to Use Outdated Methods

Scientists Continue to Use Outdated Methods

By | January 9, 2018

The use of underperforming computational tools is a major offender in science’s reproducibility crisis—and there’s growing momentum to avoid it.

3 Comments

image: Maternal Response to Zika Damages Mouse Fetuses

Maternal Response to Zika Damages Mouse Fetuses

By | January 5, 2018

Signaling pathways triggered by the mother’s immune system may cause complications during fetal development.

1 Comment

image: Antiviral Immunotherapy Comes of Age

Antiviral Immunotherapy Comes of Age

By | December 4, 2017

T-cell therapies are not just for cancer. Researchers are also advancing immunotherapy methods to protect bone marrow transplant patients from viral infections. 

0 Comments

A single receptor on natural killer cells recognizes an amino acid sequence conserved across Zika, dengue, and related pathogens.

0 Comments

image: European Research Council Founder, Molecular Biologist Dies

European Research Council Founder, Molecular Biologist Dies

By | November 20, 2017

Fotis Kafatos, a Greek researcher famous for his work on malaria, has died at age 77.

0 Comments

The former chief of Eli Lilly USA is picked to replace Tom Price, who stepped down in September amid a controversy over the abuse of taxpayer-funded travel.

0 Comments

A team has engineered two stem cell lines into “synthetic T cells” that destroy breast cancer cells in vitro. 

1 Comment

image: FDA Approves Second CAR T-Cell Therapy

FDA Approves Second CAR T-Cell Therapy

By | October 19, 2017

The therapy, produced by Kite Pharma and owned by Gilead Sciences, is approved for use against some types of large B-cell lymphomas. 

0 Comments

Popular Now

  1. Secret Eugenics Conference Uncovered at University College London
  2. How Do Infant Immune Systems Learn to Tolerate Gut Bacteria?
  3. That Other CRISPR Patent Dispute
    Daily News That Other CRISPR Patent Dispute

    The Broad Institute and Rockefeller University disagree over which scientists should be named as inventors on certain patents involving the gene-editing technology.

  4. DOE-Sponsored Oak Ridge National Laboratory to Cut 100 More Jobs
AAAS